Cytarabine hepatotoxicity
WebDec 2, 2016 · Cytarabine (Ara C) is considered the most effective chemotherapeutic agent in acute myeloid leukemia (AML) treatment. Several studies suggest that single nucleotide polymorphisms (SNPs) within the genes involving metabolic pathway of Ara C could influence in treatment outcomes, although their clinical relevance remains undetermined. … WebJun 1, 2024 · Purpose: Cytarabine is considered the standard of care for induction therapy in patients with acute myeloid leukemia (AML) who are preparing for bone marrow transplant.Summary: We report a case of a 72-year-old female presenting to the intensive care unit with hepatic failure after high-dose cytarabine (HiDAC) for the treatment of …
Cytarabine hepatotoxicity
Did you know?
WebJul 15, 2024 · Hepatotoxicity represents a relatively common and potentially serious side effect of anticancer therapies. Hepatotoxicity can manifest in many different ways … WebAra-C. Cytarabine is the generic name for the trade name drug Cytosar-U®. In some cases, health care professionals may use the name Ara-C or arabinosylcytosine when referring to the generic drug name cytarabine. Drug type: Cytarabine is an anti-cancer ("antineoplastic" or "cytotoxic") chemotherapy drug. This medication is classified as an ...
WebChemotherapy hepatotoxicity and dose modification in patients with liver disease: Conventional cytotoxic agents …contemporary reports, cytarabine infrequently causes histologically proven cholestasis . Furthermore, transiently abnormal LFTs developed in 24 of 27 patients undergoing high-dose cytarabine by 72-hour continuous … WebChemotherapy hepatotoxicity and dose modification in patients with liver disease: Conventional cytotoxic agents …contemporary reports, cytarabine infrequently causes …
WebCytarabine Hepatic Renal Yes (renal) Dacarbazine Hepatic Renal Consider (renal) Daunorubicin Hepatic Hepatic Yes (hepatic) ... Imatinib mesylate Hepatic Renal, feces Yes (for hepatotoxicity on treatment) Interferon- Renal Renal No Interleukin-2 Renal Renal No Irinotecan Hepatic Renal, hepatic Yes (hepatic) Ixabepilone Hepatic Yes (hepatic) WebNov 24, 2024 · Cytarabine may cause serious side effects. Call your doctor at once if you have: severe drowsiness, confusion, unusual thoughts or behavior; fever, chills, body …
WebGastrointestinal toxicity, anorexia, nausea, vomiting and diarrhea have been reported to occur but are mild to moderate in severity and rarely require hospitalization. • Rarely …
WebDec 2, 2016 · The 30- and 60-day mortality rates were 0% and 7%, respectively. Of the 40 efficacy evaluable patients, best responses include 24 CR (60%), 7 CRi (18%), and 4 morphologic leukemia-free state (10%) with a CR+CRi (CRc) rate of 78%; 94% of CR or CRi responses occurred with 1 cycle of induction therapy. port orchard outdoor diningWebJun 1, 2024 · This topic review will cover the clinical use of high-dose MTX for treatment of malignancy, focusing on the prevention and management of toxicity. Intrathecal use of MTX and clinical use of low-dose and intermediate-dose MTX for both malignant and nonmalignant (eg, rheumatologic) conditions are covered elsewhere. (See appropriate … iron mayhem bristol vaWebAug 12, 2024 · Cytarabine is a pyrimidine analog and is also known as arabinosylcytosine (ARA-C). It is converted into the triphosphate form within the cell and competes with … iron max phytoWebDec 4, 2024 · First 2 cycles result in mild to moderate renal dysfunction, hepatotoxicity, cytopenias Reduce dose by 50% for severe liver impairment (Child-Pugh score for … iron materials near meWebThe DILIrank dataset consists of 1,036 FDA-approved drugs that are divided into four classes according to their potential for causing drug-induced liver injury (DILI). The DILI classification is... iron maven characterWebJun 1, 2024 · The most common adverse effects of cytarabine include myelosuppression, nausea, vomiting, diarrhea, and immune-suppression related infection. 5, 9 There is minimal published literature to establish a definitive link between cytarabine and hepatotoxicity. This is further complicated by the varying dosages of HiDAC. iron materials saleWebNeurotoxicity from high-dose cytarabine, a pyrimidine metabolite used in treatment for acute myeloid leukemia, is a known but dose-limiting toxicity which has incidences in up to 14% in patients receiving high doses of the drug. Neurologic symptoms vary but range from somnolence and ataxia to more severe complications such as seizures and even ... port orchard parcel